The DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants.
Open accessPublished version of a preprint
Abstract
Preterm infants (<32 weeks gestation) are highly susceptible to necrotizing enterocolitis (NEC) and sepsis, which is exacerbated by prolonged antibiotic exposure. In this study, we profiled the gut microbiota and resistome of very-low-birth-weight (VLBW) preterm infants receiving antibiotic and probiotic therapies. We constructed over 300 metagenome-assembled genomes and obtained ~90 isolate genomes via targeted culturomics, allowing strain-level analysis. We also assessed ex vivo horizontal gene transfer (HGT) capacity of multidrug-resistant (MDR) Enterococcus using neonatal gut models. Here we show that probiotic supplementation significantly reduced antibiotic resistance gene prevalence, MDR pathogen load, and restored typical early-life microbiota profile. However, persistent MDR pathogens like Enterococcus, with high HGT potential, underscore the need for continued surveillance. Our findings underscore the complex interplay between antibiotics, probiotics, and HGT in shaping the neonatal microbiome and support further research into probiotics for antimicrobial stewardship in preterm populations.
Overview
CoChat Summary
TL;DR
This study compared 34 very-low-birth-weight preterm infants with and without probiotic supplementation and found that probiotics were associated with a more Bifidobacterium-dominated microbiome and lower antibiotic resistance gene (ARG) burden. Antibiotic exposure and hospital transmission still shaped the neonatal gut resistome, with persistent multidrug-resistant Enterococcus and evidence of plasmid-mediated ARG transfer.
Key findings
- Across the first 3 weeks of life, the probiotic-supplemented (PS) cohort had significantly higher Bifidobacterium abundance, while the non-probiotic-supplemented (NPS) cohort had more pathobionts including Klebsiella, Enterobacter, Escherichia, Enterococcus, and Staphylococcus.
- ARG abundance was significantly higher in NPS infants than PS infants across the first 3 weeks; NPS guts also contained more ARG types, especially in weeks 2 and 3.
- Genome-resolved analysis recovered 322 high-quality MAGs and 89 isolate genomes, then 195 representative strains; among these, Enterococcus, Escherichia, Klebsiella, and Staphylococcus were the four most resistant genera.
- In metagenomes, plasmid counts were significantly higher in NPS than PS infants, and plasmid replicon count and ARG count were weakly positively correlated overall (τ = 0.33; P = 0.00001), stronger in antibiotic-treated infants (τ = 0.43, P < 0.0001).
- The ex vivo Enterococcus model showed successful transfer of a ~137 kb mega-plasmid carrying aac6-aph2, which conferred gentamicin resistance to a plasmid-free recipient strain.
- The study identified 6 Enterococcus strains circulating among infants by 99.9% ANI, including identical strains across unrelated infants in both hospitals, suggesting nosocomial transmission.
Methods
- Controlled sub-study of a prior observational cohort: 34 VLBW preterm infants from 92 samples; all were human-milk-fed, with PS vs NPS cohorts and antibiotic-treated vs control infants within each cohort.
- Shotgun metagenomic sequencing of longitudinal faecal samples from weeks 1–3, plus culturomics and genome-resolved metagenomics to recover MAGs and isolate genomes for strain-level microbiome/resistome analysis.
- ARGs, plasmid replicons, MLST, ANI, HGT, and functional profiling were assessed with sequence-based bioinformatics; an ex vivo neonatal gut model was used to test Enterococcus plasmid transfer.
Limitations
- The paper states that the 3-week sampling window was relatively short and could not capture longer-term effects of antibiotics and probiotics.
- The study used samples from two hospital sites, which could introduce site-specific environmental or clinical confounding; the authors say prior work found no significant site effect, but they still acknowledge this as a potential limitation.
- The paper states that low-abundance ARGs may have been missed because of sequencing coverage limits; it also notes that 7.9% of ARGs were seen in isolate genomes but not in matching metagenomes.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
11 Valid · 0 Not valid · 2 Not checked · 100 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“To assess clinical relevance, we sequence-typed a total of 193 key resistant pathobiont genomes from Escherichia, Klebsiella, Enterococcus, and Staphylococcus (Fig. 3f) using the multi-locus sequence typing (MLST)33 scheme.”
§ Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants > Results > Strain-level gut-derived pathobiont resistome analysis
What the sources say
- Supportedcites [33] Jolley, K. A., Bray, J. E. & Maiden, M. C. J. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 3, 124 (2018). source
The citation is attached to the MLST scheme, not to the citing authors’ own count of 193 genomes. The source’s Introduction (page unavailable) describes conventional seven-locus MLST schemes as available in PubMLST databases, supporting the method citation. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This decrease could potentially be attributed to the carbon source depletion promoted by Bifidobacterium specialised HMO utilisation in human milk-fed gut environment, which may inhibit pathobiont colonisation and growth39,40.”
§ Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants > Discussion
What the sources say
- Partly supportedcites [39] Sprockett, D., Fukami, T. & Relman, D. A. Role of priority effects in the early-life assembly of the gut microbiota. Nat. Rev. Gastroenterol. Hepatol. 15, 197–205 (2018). sourceExperimental — accuracy not yet measured
In “Priority effects in the infant gut” (page unavailable), the paper says Bifidobacterium consumes breast-milk HMOs and likely depletes those carbon sources, limiting later species’ colonization. It does not identify Enterococcus as an affected species or show that this mechanism explains its decrease or inhibits pathobiont growth specifically. (LLM, conf=0.86)
- Partly supportedcites [40] Horrocks, V., King, O. G., Yip, A. Y. G., Marques, I. M. & McDonald, J. A. K. Role of the gut microbiota in nutrient competition and protection against intestinal pathogen colonization. Microbiol. 169, 001377 (2023). sourceExperimental — accuracy not yet measured
Split into 2 atoms — 1 confirmed, 1 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“PS infants showed an earlier and more robust colonisation of infant-associated Bifidobacterium species, particularly B. breve and B. longum subsp. infantis, compared to NPS infants51–53.”
§ Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants > Discussion
What the sources say
- Partly supportedcites [51] Underwood, M. A., German, J. B., Lebrilla, C. B. & Mills, D. A. Bifidobacterium longumsubspecies infantis: champion colonizer of the infant gut. Pediatr. Res. 77, 229–235 (2015). sourceExperimental — accuracy not yet measured
The 'Human Milk Oligosaccharides Shape the Infant Intestinal Microbiota' section identifies B. breve and B. infantis as species that colonize infants. The 'B. infantis in Premature Infants' section reports stronger colonization by B. infantis than by B. lactis under the conditions studied, but our copy does not report earlier or more robust colonization of both named species in PS infants compared with NPS infants. Page numbers were not supplied. (LLM, conf=0.83)
- Partly supportedcites [52] Turroni, F. et al. Diversity of bifidobacteria within the infant gut microbiota. PloS One 7, e36957 (2012). sourceExperimental — accuracy not yet measured
The Results sections on core microbiota and interindividual variability (page not provided) identify B. breve and B. longum in infant samples. They do not identify B. longum subsp. infantis or compare PS with NPS infants, so they cannot support the claimed earlier or more robust colonisation in PS infants. (LLM, conf=0.82)
- Not checked — no full text of the sourcecites [53] Samara, J. et al. Supplementation with a probiotic mixture accelerates gut microbiome maturation and reduces intestinal inflammation in extremely preterm infants. Cell Host Microbe 30, 696–711.e695 (2022). source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“our results also showed that PS infants harboured significantly fewer ARGs than NPS infants29.”
§ Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants > Discussion
What the sources say
- Partly supportedcites [29] Guitor, A. K. et al. Capturing the antibiotic resistome of preterm infants reveals new benefits of probiotic supplementation. Microbiome 10, 136 (2022). sourceExperimental — accuracy not yet measured
The Results section reports significantly fewer *unique* ARGs per PS infant than per NS infant at several visits. But the Results and Discussion also state that the overall number of ARGs did not differ significantly between groups. The claim omits the distinction between unique ARGs and ARGs overall. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Indeed, we identified specific STs linked to neonatal infections, such as E. coli ST119347, ST73 and ST9547,48, and K. pneumoniae ST43249 strains, which are typically drug-resistant strains and of clinical significance.”
§ Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants > Discussion
What the sources say
- Not checked — no full text of the sourcecites [47] Nhu, N. T. K. et al. High-risk Escherichia coli clones that cause neonatal meningitis and association with recrudescent infection. Elife 12, RP91853 (2024). source
- Not checked — no full text of the sourcecites [48] Riley, L. W. Pandemic lineages of extraintestinal pathogenic Escherichia coli. Clin. Microbiol. Infect. 20, 380–390 (2014). source
- Partly supportedcites [49] Weng, Y. et al. Multicenter study of colistin heteroresistance in carbapenem-resistant Klebsiella pneumoniae strains in China. Microbiol. Spectr. 11, e0221822 (2023). sourceExperimental — accuracy not yet measured
The Observation section reports one K. pneumoniae ST432 isolate, and Table 1 identifies it as a blood isolate carrying the KPC-2 carbapenemase gene. The paper does not link that isolate to a neonatal infection or establish that ST432 strains are typically drug-resistant; it studies one resistant ST432 isolate. The E. coli sequence types are attached to other citations, not this one. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
55 more claims
Create a free account to see all 113 claims and every source verdict.
- It may state two separate claims as one. 44
- Probably not a substantial claim. 14
Citations
Cites
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
fastp: an ultra-fast all-in-one FASTQ preprocessor
Chen, S., Zhou, Y., Chen, Y., & Gu, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty560 · Cited by 29,721
SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing
Bankevich, A., Nurk, S., Antipov, D., Gurevich, A. A., Dvorkin, M., Kulikov, A. S., Lesin, V. M., Nikolenko, S. I., Pham, S., Prjibelski, A. D., et al. (2012) · Journal of Computational Biology · doi:10.1089/cmb.2012.0021 · Cited by 25,987
Dermyshi, E., Wang, Y., Yan, C., Hong, W., Qiu, G., Gong, X., & Zhang, T. (2017) · Neonatology · doi:10.1159/000454668 · Cited by 24,451
Wickham, H., Averick, M., Bryan, J., Chang, W., McGowan, L., François, R., Grolemund, G., Hayes, A., Henry, L., Hester, J., et al. (2019) · Journal of Open Source Software · doi:10.21105/joss.01686 · Cited by 22,138
Prokka: rapid prokaryotic genome annotation
Seemann, T. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu153 · Cited by 18,818
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Twelve years of SAMtools and BCFtools
Danecek, P., Bonfield, J. K., Liddle, J., Marshall, J., Ohan, V., Pollard, M. O., Whitwham, A., Keane, T., McCarthy, S. A., Davies, R. M., et al. (2021) · GigaScience · doi:10.1093/gigascience/giab008 · Cited by 15,343
Minimap2: Pairwise alignment for nucleotide sequences
Li, H. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty191 · Cited by 14,807
Wickham, H. (2016) · Use R! · doi:10.1007/978-3-319-24277-4_9 · Cited by 12,516
Cited by
Microbial metabolites in tumor epigenetic regulation
Zhang, W., Zhang, H., Liao, Y., Jiang, S., Zhang, H., Huang, C., Song, Z., Zhao, R., Lü, P., Kang, X., et al. (2026) · iMeta · doi:10.1002/imt2.70115 · Cited by 19
The Gut Microbiome and Colistin Resistance: A Hidden Driver of Antimicrobial Failure
Miftode, I.-L., Vâţă, A., Miftode, R.-Ş., Oancea, A. F., Pasare, M. A., Părângă, T. G., Miftode, E. G., Mititiuc, I. L., & Radu, V. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26188899 · Cited by 15
“These findings demonstrate the capacity of probiotic supplementation not only to restore microbial balance but also to reduce the neonatal resistome footprint under antibiotic pressure [86].”
Profiling the gut resistome to unlock antimicrobial resistance biology and inform clinical risk
Chaudhry, Z., Cazares, A., Thomson, N. R., & Heyderman, R. S. (2026) · Nature Communications · doi:10.1038/s41467-026-75659-5 · Cited by 7
He, X., Zhao, E., Song, X. Y., Zhao, Q., Liu, J. J., Zhang, B., Xu, H., Fang, Y., Wei, X., Zhu, Y., et al. (2026) · Environmental Research · doi:10.1016/j.envres.2026.124532 · Cited by 4
Predicting macrosomia and low birth weight with interpretable machine learning
Cui, M., Yang, H., Wang, B., Zhang, J., Chu, Q., Zhang, C., Yao, Z., & Wang, L. (2026) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-026-08667-4 · Cited by 2
“Neonatal birth weight serves as a critical biomarker of infant health, effectively reflecting intrauterine growth conditions and providing significant predictive value for both short-term and long-term health outcomes [1, 2].”
Metadata
- Authors
- Kiu, R., Darby, E. M., Alcon-Giner, C., Acuna-Gonzalez, A., Camargo, A., Lamberte, L. E., Phillips, S., Sim, K., Shaw, A. G., Clarke, P., van Schaik, W., Kroll, J. S., & Hall, L. J.
- Affiliations
- Norwich Research Park (GB)
- University of Birmingham (GB)
- Imperial College London (GB)
- University of East Anglia (GB)
- Corresponding author
- Kiu, Raymond
- Hall, Lindsay J.
- Venue
- Nature communications
- Published
- 2025-08-14
- Volume
- 16
- Issue
- 1
- Pages
- 7569-7569
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC12354744
- OpenAlex
- W4413140743
- Cited by
- 36
- References
- 115
- Citations by year
- 2026: 32 · 2025: 5
- FWCI
- 11.57
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, other-oa)
- PubMed (publishedVersion)
- UEA Digital Repository (University of East Anglia) (acceptedVersion, cc-by)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, cc-by)
- PubMed Central (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Wellcome Trust (100974/C/13/Z)
- RCUK | Biotechnology and Biological Sciences Research Council (BB/R012490/1, BB/X011054/1, BB/S017941/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Keywords
- preterm infants, very low birth weight infants, probiotics, antibiotics, gut microbiota, resistome, antibiotic resistance genes, horizontal gene transfer
- MeSH terms
- Gastrointestinal Microbiome, Anti-Bacterial Agents
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants. https://app.cochat.ai/papers/10.1038/s41467-025-62584-2
- The paper
- Kiu, R., Darby, E. M., Alcon-Giner, C., Acuna-Gonzalez, A., Camargo, A., Lamberte, L. E., Phillips, S., Sim, K., Shaw, A. G., Clarke, P., van Schaik, W., Kroll, J. S., & Hall, L. J. (2025). Impact of early life antibiotic and probiotic treatment on gut microbiome and resistome of very-low-birth-weight preterm infants. Nature communications. https://doi.org/10.1038/s41467-025-62584-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.